BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 19182495)

  • 1. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH; Oh J; Roh JH; Huh K
    Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
    J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
    Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
    Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
    Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Br J Ophthalmol; 2007 Jun; 91(6):822-6. PubMed ID: 17229797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
    Wang F; Xu X; Zhang X; Yan Y
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.